Browsing by Author Baran, Yusuf

Showing results 29 to 48 of 173 < previous   next >
Issue DateTitleAuthor(s)
Jun-2010Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cellsBaran, Yusuf ; Öztekin, Coşkun; Başsoy, Esen Yonca
Sep-2014Comparative development of knowledge-based bioeconomy in the European Union and TurkeyÇelikkanat Ozan, Didem; Baran, Yusuf 
2014Comparison of ishage-based CD34 (+) cell enumeration protocols on BD facs canto ıı and attune flow cytometersKozanoğlu, İlknur; Ünver, Gülşah; Sarıtürk, Çağla; Baran, Yusuf ; Yeral, Mahmut; Boğa, Can; Özdoğu, Hakan
2012Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemiaBaran, Yusuf ; Saydam, Güray
2014Cytotoxic and apoptotic effects of fisetin, hesperetin and vitexinon acute promyelocytic leukemia cellsAdan Gökbulut, Aysun ; Baran, Yusuf 
2014Cytotoxic and cytostatic effects of ponatinib on imatinib-sensitive and-resistant chronic myeloid leukemia cellsYandım, Melis Kartal; Baran, Yusuf 
2013Cytotoxic effects of apigenin on multiple myeloma cellsBaran, Yusuf ; Yılmaz, S. ; Cincin, Zeynep; Kozanoğlu, İlknur; Çakmakoğlu, Bedia; Özdoğu, Hakan
2010Cytotoxic effects of resveratrol on imatinib sensitive and resistant K562 chronic myeloid leukemia cellsCan, Geylani; Baran, Yusuf 
2011Deciphering 5-fluorouracil mediated molecular mechanisms required for cell deathCan, Geylani
2013Determination of cytotoxic and apoptotic effects of caffeic acid phenethyl ester and gossypol in combination with fludarabine at a molecular level in acute lymphoblastic leukemia cellsBaran, Yusuf ; İskender, G.; Pişkin, Özden; Özcan, Mehmet Ali
Jul-2021Determination of therapeutic effects of multifunctional antibody and peptide micelle-based nanocarriers on breast cancer cellsAbdulhadi, Nusaibah Abdulsalam Abdulhad
2021Determination of therapeutic effects of multifunctional micelle-based nanocarriers on breast cancer cellsUlu, Gizem Tuğçe ; Bayram, Nazende Nur; Abdulhadi, N.; Gurdap, S.; Isoglu, A.; Isoglu, S. D.; Baran, Yusuf 
Jul-2019Determination of therapeutic effects of multifunctional micelle-based nanocarriers on breast cancer cellsUlu, Gizem Tuğçe 
Dec-2019Determination of therapeutic potential of apigenin on acute lymphoblastic leukemia cellsUzuner, Erez
Nov-2019Determination of therapeutic potential of luteolin for acute lymphoblastic leukemia cellsGürler, Sevim Beyza
2020Determination of therapeutic potential of luteolin for Philadelphia chromosome positive acute lymphoblastic leukaemia cellsGürler, Sevim Beyza; Baran, Yusuf ; Kiraz, Yağmur 
2013Diagnostic and therapeutic potentials of expression levels of bioactive sphingolipid genes in newly diagnosed and drug-resistant chronic myeloid leukemia patientsBaran, Yusuf ; Yandım, Melis; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, Özden; Özcan, Mehmet Ali
2015Discovering alternative targets in chronic myeloid leukemia (CML): determination of expression levels of bioactive sphingolipid genes in newly diagnosed and drug-resistant CML patientsKartal Yandım, Melis; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, Özden; Özcan, Mehmet Ali; Baran, Yusuf 
Jun-2009Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cellsGüçlüler, Gözde; Baran, Yusuf 
Feb-2009Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cellsKarabulut, B.; Erten, C.; Gül, M. K.; Cengiz, E.; Karaca, B.; Küçükzeybek, Y.; Görümlü, G.; Atmaca, H.; Uzunoğlu, S.; Şanlı, U. A.; Baran, Yusuf ; Uslu, R.